Loading...
TherapeuticsMD, a pharmaceutical royalty company, reported its financial results for the third quarter ended September 30, 2024. The company is primarily collecting royalties from its licensees.
TherapeuticsMD reported financial results for Q3 2024.
The company is a pharmaceutical royalty company.
TherapeuticsMD primarily collects royalties from its licensees.
The company is no longer engaging in research and development or commercial operations.
Analyze how earnings announcements historically affect stock price performance